Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)

被引：57

作者：

Herrmann, G

Engert, A

Hunzelmann, N

机构：

[1] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany

[2] Univ Cologne, Dept Internal Med, D-50931 Cologne, Germany

来源：

关键词：

D O I：

10.1046/j.1365-2133.2003.05209_10.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：602 / 603

页数：2

共 7 条

[1]

BACHMANN MF, 1994, J IMMUNOL, V153, P3386

Hayag, MV ;

Cohen, JA ;

Kerdel, FA .

[3]

Heizmann M, 2001, AM J HEMATOL, V66, P142, DOI 10.1002/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO

[4]

2-0

[5]

Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO

[6]

2-1

[7] Pathophysiology and therapy of pemphigus in the 21st century [J].

Stanley, JR .